Evaluate, a Norstella company, announces acquisition of J+D Forecasting

Published on January 10, 2024

January 8, 2024, London, UK and Boston, MA – Evaluate, a Norstella company, announced today the acquisition of J+D Forecasting, a leading provider of forecasting solutions for the pharmaceutical industry.

Continue reading on website
Other news

Emerus Hospital Receives National Recognition for Excellence in Patient Experience

January 9, 2024
AHN Harmar Neighborhood Hospital in Pittsburgh Earns Prestigious Press Ganey HonorSource: PRNewswireEmerus Holdings Inc. is proud to announce that one of its partner hospitals, AHN Harmar Neighborhood Hospital in Pittsburgh, has been honored as a 2023 Press Ganey Human Experience Award Winner, recognized as the “Guardian of Excellence” in Patient Experience – Emergency Department.“I am so proud of

IPI Article: Immunogenicity Management in Biologics

January 15, 2024
In a recent article in the International Pharmaceutical Industry Journal, Abzena’s Chief Scientific Officer, Campbell Bunce PhD MBA, and VP of Research and Innovation of Protein Engineering, Rob Holgate, delve into the changing landscape of immunogenicity management and assessments.Within the article, they detail how a combination of innovative technologies, collaborative regulatory framework, and